Farrell D, McCarthy G, Savage E (2016) Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease. J Crohns Colitis 10(3):315–322

Article  PubMed  Google Scholar 

Borren NZ, van der Woude CJ, Ananthakrishnan AN (2019) Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol 16(4):247–259

Article  PubMed  Google Scholar 

Barberio B et al (2021) Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 6(5):359–370

Article  PubMed  Google Scholar 

Fairbrass KM et al (2022) Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up. Aliment Pharmacol Ther 56(8):1264–1273

Article  PubMed  Google Scholar 

Bisgaard TH et al (2022) Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol 19(11):717–726

Article  PubMed  Google Scholar 

Andoh A, Nishida A (2023) Alteration of the Gut Microbiome in Inflammatory Bowel Disease. Digestion 104(1):16–23

Article  PubMed  Google Scholar 

Caruso R, Lo BC, Núñez G (2020) Host-microbiota interactions in inflammatory bowel disease. Nat Rev Immunol 20(7):411–426

Article  PubMed  Google Scholar 

Pittayanon R et al (2020) Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology 158(4):930-946.e1

Article  PubMed  Google Scholar 

Dinan TG, Cryan JF (2020) Gut microbiota: a missing link in psychiatry. World Psychiatry 19(1):111–112

Article  PubMed  PubMed Central  Google Scholar 

Valles-Colomer M et al (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4(4):623–632

Article  PubMed  Google Scholar 

Person H, Keefer L (2021) Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry 107:110209

Article  PubMed  Google Scholar 

Han L et al (2022) Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity. Isme j 16(4):983–996

Article  PubMed  Google Scholar 

Staudacher HM et al (2023) Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol 20(9):582–596

Article  PubMed  Google Scholar 

Akkasheh G et al (2016) Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32(3):315–320

Article  PubMed  Google Scholar 

Allen AP et al (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6(11):e939

Article  PubMed  PubMed Central  Google Scholar 

Benton D, Williams C, Brown A (2007) Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61(3):355–361

Article  PubMed  Google Scholar 

Chong H et al (2019) Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. Beneficial microbes 10(4):355–373

Article  PubMed  Google Scholar 

Freijy TM et al (2023) Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial. Front Neurosci 16:1097278

Article  PubMed  PubMed Central  Google Scholar 

Hadi A et al (2019) Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial. Complement Ther Med 47:102216

Article  PubMed  Google Scholar 

Haghighat N, Rajabi S, Mohammadshahi M (2021) Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial. Nutr Neurosci 24(6):490–499

Article  PubMed  Google Scholar 

Kazemi A et al (2019) Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr 38(2):522–528

Article  PubMed  Google Scholar 

Kelly JR et al (2017) Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 61:50–59

Article  PubMed  Google Scholar 

Lau RI et al (2024) A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 24(3):256–265

Article  PubMed  Google Scholar 

Lorenzo-Zúñiga V et al (2014) I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 20(26):8709–16

Article  PubMed  PubMed Central  Google Scholar 

Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F (2018) Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food Nutr Res 62. https://doi.org/10.29219/fnr.v62.1218

Messaoudi M et al (2011) Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105(5):755–764

Article  PubMed  Google Scholar 

Messaoudi M et al (2011) Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2(4):256–261

Article  PubMed  Google Scholar 

Mysonhimer AR et al (2023) Prebiotic consumption alters microbiota but not biological markers of stress and inflammation or mental health symptoms in healthy adults: a randomized, controlled. Crossover Trial J Nutr 153(4):1283–1296

PubMed  Google Scholar 

Obermoser K et al (2023) Positive Effects of Probiotic Therapy in Patients with Post-Infectious Fatigue. Metabolites 13(5):639

Article  PubMed  PubMed Central  Google Scholar 

Östlund-Lagerström L et al (2016) Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial. Nutr J 15(1):80

Article  PubMed  PubMed Central  Google Scholar 

Pinto-Sanchez MI et al (2017) Probiotic bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153(2):448-459.e8

Article  PubMed  Google Scholar 

Rao AV et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut pathogens 1:1–6

Article  Google Scholar 

Romijn AR et al (2017) A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry 51(8):810–821

Article  PubMed  PubMed Central  Google Scholar 

Schmidt K et al (2015) Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 232(10):1793–1801

Article  PubMed  Google Scholar 

Steenbergen L et al (2015) A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48:258–264

Article  PubMed  Google Scholar 

Vidot H et al (2019) Supplementation with synbiotics and/or branched chain amino acids in hepatic encephalopathy: a pilot randomised placebo-controlled clinical study. Nutrients 11(8):1810

Article  PubMed  PubMed Central  Google Scholar